Posted on October 12, 202110/12/21
WEBINAR: A Pivotal Shift in Life Sciences Industry Across R&D and Commercial: A Conversation with the Experts
Posted on July 14, 20217/14/21
Navigating the Transition to Post-Approval Pharmacovigilance With EVERSANA and ArisGlobal
Posted on May 14, 20215/14/21
Breaking Up Is Hard to Do: When to Leave Your CRO for Optimized Pharmacovigilance
Posted on February 12, 20212/12/21
Supporting Successful Commercialization With Integrated Compliance
Posted on December 9, 202012/9/20
COVID-19 Vaccine Safety Briefing Report
Posted on December 3, 202012/3/20
What Happens After a COVID-19 Vaccine Trial Succeeds? 4 Pharmacovigilance Challenges to Address During Commercialization
Posted on October 1, 202010/1/20
Compliance – The Competitive Differentiator to Commercialization: An Integrated Model Setting the New Global Standard
Posted on October 17, 201910/17/19
Adopting a Patient-Centric Approach to Ensure Safe and Effective Use
Posted on October 9, 201910/9/19
Innovative Therapies Call for an Integrated Drug Safety and Compliance Model
Posted on October 4, 201910/4/19